RR6

CAS : 1351758-37-6

Ref. 3D-BEC75837

Informations sur le produit

• Nom: RR6
• Synonymes: (2R)-2-Hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide

Description

RR6 is a glycol ether that is used in the treatment of metabolic disorders. It activates AMP-activated protein kinase (AMPK) and inhibits ATP citrate lyase, thereby increasing acetyl-CoA levels and decreasing fatty acid synthesis. RR6 also reduces oxidative stress by inhibiting the production of reactive oxygen species and inhibiting mitochondrial permeability transition pore opening. This drug has been shown to be effective against choroidal neovascularization, which may be due to its ability to reduce vascular endothelial growth factor levels. RR6 is a small molecule that can be administered orally or intravenously, making it an attractive candidate for drug development.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 298.39 g/mol
• Formule: C₁₆H₁₈D₅NO₄
• Degré de pureté: Min. 95%